[Federal Register Volume 66, Number 201 (Wednesday, October 17, 2001)]
[Notices]
[Page 52781]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-26019]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 25, 2001, Celgene 
Corporation, 7 Powder Horn Drive, Warren, New Jersey 07059, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of methylphenidate (1724) a basic 
class of controlled substance listed in Schedule II.
    The firm plans to manufacture methylphenidate for product research 
and development.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than December 17, 2001.

    Dated: October 5, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-26019 Filed 10-16-01; 8:45 am]
BILLING CODE 4410-09-M